Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide (Q41854078)
Jump to navigation
Jump to search
scientific article published on November 25, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide |
scientific article published on November 25, 2010 |
Statements
1 reference
Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide (English)
1 reference
Pierre Fenaux
1 reference
Aristoteles Giagounidis
1 reference
Gudrun Göhring
1 reference
Guntram Büsche
1 reference
Winfried Hofmann
1 reference
Hans Heinrich Kreipe
1 reference
Eva Hellström-Lindberg
1 reference
Aristoteles Giagounidis
25 November 2010
1 reference
1 reference
319-322
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference